Skip to main content

Table 1 Patients characteristics

From: Assessment of bacterial diversity associated with assisted reproductive technologies through next-generation sequencing

Variables

Total (N = 255)

P group (N = 99)

NP group (N = 98)

P value

Age (years)

33.24 ± 5.57

30.89 ± 4.90

33.42 ± 5.92

0.00

Anti-Mullerian hormone (ng/ml)

2.3 (1.2–2.5)

2.8 (1.3–2.4)

2.3 (1.2–2.3)

0.53

Antral follicle count (n)

11.0 (5.0–6.0)

10.0 (6.0–8.0)

9 .0 (6.0–7.0)

0.56

Luteinizing hormone (mIU/ml)

8.06 (2.90–14.01)

8.95 (3.19–15.42)

7.82 (2.60–12.98)

0.52

Estrogen (pg/ml)

392.21 (216.85–1439.28)

403.84 (213.29–1501.59)

380.07 (223.82–1431.36)

0.52

Progesterone (ng/ml)

0.45 (0.30–0.67)

0.49 (0.33–0.67)

0.42 (0.29–0.67)

0.34

Endometrium thickness (mm)

9 .0 (8.50–10.00)

9.20 (8.50–10.00)

8.90 (8.18–10.00)

0.03

Number of retrieved oocytes

9 .0 (7.0–8.0)

9.0 (6.0–8.0)

10 (5.0–9.0)

0.69

Number of MII oocytes

9.0 (4–7)

8.0 (3–7)

7.0 (4–7)

0.27

Number of transferred embryos

2 (1,2)

2 (2)

2 (2)

0.39

  1. P pregnancy group, NP non-pregnancy group, p < 0.05 indicates significant difference between groups